March 7, 2023, Rochester, MN – Emmyon is pleased to announce that it has received a new Phase II Small Business Innovation Research (SBIR) award from the National Cancer Institute (NCI), a division of the U.S. National Institutes of Health (NIH). The funding will support development of therapeutics for cancer-induced skeletal muscle wasting. We are very grateful to the NCI and the NIH for their support of these efforts.